All demographic, clinical, and neuropsychological parameters as well as tau plasma, and CSF levels of Aβ42, tau, and p-tau181 for HC and SCD with available CSF are displayed in Table 2. The gene discussed is MAPT; the disease is Schnyder corneal dystrophy.